Recent advances and impending challenges for the radiopharmaceutical sciences in oncology.

Lapi SE, Scott PJH, Scott AM, Windhorst AD, Zeglis BM, Abdel-Wahab M, Baum RP, Buatti JM, Giammarile F, Kiess AP, Jalilian A, Knoll P, Korde A, Kunikowska J, Lee ST, Paez D, Urbain JL, Zhang J, Lewis JS

Open source

DOI: 10.1016/s1470-2045(24)00030-5
Published: 2024 Jun
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-24-00030-5,
  title = {Recent advances and impending challenges for the radiopharmaceutical sciences in oncology.},
  author = {Lapi SE and Scott PJH and Scott AM and Windhorst AD and Zeglis BM and Abdel-Wahab M and Baum RP and Buatti JM and Giammarile F and Kiess AP and Jalilian A and Knoll P and Korde A and Kunikowska J and Lee ST and Paez D and Urbain JL and Zhang J and Lewis JS},
  year = {2024},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(24)00030-5},
  url = {https://doi.org/10.1016/s1470-2045(24)00030-5}
}

RIS

TY  - JOUR
TI  - Recent advances and impending challenges for the radiopharmaceutical sciences in oncology.
AU  - Lapi SE
AU  - Scott PJH
AU  - Scott AM
AU  - Windhorst AD
AU  - Zeglis BM
AU  - Abdel-Wahab M
AU  - Baum RP
AU  - Buatti JM
AU  - Giammarile F
AU  - Kiess AP
AU  - Jalilian A
AU  - Knoll P
AU  - Korde A
AU  - Kunikowska J
AU  - Lee ST
AU  - Paez D
AU  - Urbain JL
AU  - Zhang J
AU  - Lewis JS
PY  - 2024
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(24)00030-5
UR  - https://doi.org/10.1016/s1470-2045(24)00030-5
ER  -

APA

SE, L., PJH, S., AM, S., AD, W., BM, Z., M, A., RP, B., JM, B., F, G., AP, K., A, J., P, K., A, K., J, K., ST, L., D, P., JL, U., J, Z., & JS, L. (2024). Recent advances and impending challenges for the radiopharmaceutical sciences in oncology.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(24)00030-5

Source records

pubmed · retrieved 2026-09-26T09:17:46.136Z